Literature DB >> 17625982

Use of health care resources and cost of care for adults with constipation.

Gurkirpal Singh1, Vijayabharathi Lingala, Huijian Wang, Shweta Vadhavkar, Kristijan H Kahler, Alka Mithal, George Triadafilopoulos.   

Abstract

BACKGROUND & AIMS: Constipation is a multisymptom disorder that frequently compromises quality of life and leads patients to seek medical advice. To evaluate the clinical and fiscal effects of constipation, we assessed health care resource use by patients with constipation enrolled in a large state Medicaid program.
METHODS: We identified 105,130 patients older than age 18 who saw a physician at least once for constipation and were enrolled in the California Medicaid program (Medi-Cal). We then studied health care resource use and costs (reimbursed by Medi-Cal) in 76,854 patients without supplementary insurance. The 15-month analysis period encompassed 3 months before and 12 months after the first visit. The prevalence of comorbid conditions was assessed in the sample of 105,130 patients.
RESULTS: During the study period, 106,555 physician visits were for constipation; the total associated cost was $3,016,017 ($39/patient). The total cost for gastrointestinal procedures and laboratory testing was $14,052,503 ($183/patient). There were 41,723 over-the-counter and 1665 prescription drug purchases; the total cost was $388,780 ($5/patient). Approximately 0.6% of patients (n = 479) were admitted to the hospital for constipation; the total cost was $1,433,708 ($2993/admission). The total direct health care costs for patients with constipation in the Medi-Cal system for the 15-month period was $18,891,008 ($246/patient). Within 12 months of the first physician visit for constipation, 5657 of 105,130 patients had hemorrhoids and 2288 had intestinal impaction or obstruction.
CONCLUSIONS: Adults seeking treatment for constipation account for significant health care resource use and often have comorbid conditions. The clinical and fiscal burden of constipation in US adults cannot be disregarded or trivialized.

Entities:  

Mesh:

Year:  2007        PMID: 17625982     DOI: 10.1016/j.cgh.2007.04.019

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

1.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

Review 2.  Dyssynergic defecation and biofeedback therapy.

Authors:  Satish S C Rao
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

3.  Multiple rectal polyps in a young woman with constipation.

Authors:  George Triadafilopoulos; Charles M Lombard
Journal:  Dig Dis Sci       Date:  2010-03-10       Impact factor: 3.199

Review 4.  Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Patrick D Meek; Samuel D Evang; Mina Tadrous; Dianne Roux-Lirange; Darren M Triller; Bora Gumustop
Journal:  Dig Dis Sci       Date:  2010-07-02       Impact factor: 3.199

5.  Probiotics Ameliorate Stool Consistency in Patients with Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Jin Young Yoon; Jae Myung Cha; Ju Kyoung Oh; Pei Lei Tan; Sae Hun Kim; Min Seob Kwak; Jung Won Jeon; Hyun Phil Shin
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

Review 6.  Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation.

Authors:  Satish S C Rao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-25       Impact factor: 11.382

7.  A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohort.

Authors:  Linda M Herrick; William M Spalding; Yuri A Saito; James Moriarty; Cathy Schleck
Journal:  J Med Econ       Date:  2016-11-10       Impact factor: 2.448

Review 8.  Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.

Authors:  Ron Schey; Satish S C Rao
Journal:  Dig Dis Sci       Date:  2011-04-27       Impact factor: 3.199

Review 9.  Update on the management of constipation in the elderly: new treatment options.

Authors:  Satish S C Rao; Jorge T Go
Journal:  Clin Interv Aging       Date:  2010-08-09       Impact factor: 4.458

10.  Impaired viscosity of gastric secretion and its mucin content as potential contributing factors to the development of chronic constipation.

Authors:  Juan Castro-Combs; Cesar J Garcia; Marek Majewski; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2014-06-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.